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Introduction 45
Acute respiratory distress syndrome (ARDS) is a major cause of mortality and morbidity in 46 intensive care unit (ARDS). The incidence of ARDS is reported to be ranged between 4 to 20 cases / 100,000 population / year according to differences in the methodology used to define ARDS or 48 ALI.[1--3] In a large cohort study involving 78 European ICUs, Brun--Buisson C and coworkers 49 reported that acute lung injury (ALI) occurred in 7.1% of ICU admissions and in 16.1% of 50 mechanically ventilated patients.
[4] ALI/ARDS is associated with a mortality rate ranging from 30% 51 to 75%, depending on different patient mix. Although some report showed a declining mortality 52 of ARDS, most cohort studies reported similar mortality rate to that of previous decades. Therefore, it could be clinically helpful to identify patients with risk of ALI/ARDS as early as 63 possible and this motivates investigators to look for risk factors of ALI/ARDS. Cigarette smoking 64 has long been established to be an important risk factor for varieties of lung diseases including 65 lung cancer and chronic obstructive pulmonary disease.[9] However, it is still unknown whether 66 cigarette smoking increases risk of ALI/ARDS in acute setting. Although several studies have 67 reported an association between smoking and ALI/ARDS, this cannot be replicated in other 68 studies.[10--13] Therefore, we conducted a systematic review and meta--analysis to explore 69 whether smoking was a true risk factor for ALI/ARDS. 70 71
Methods 72
Searching strategy and study selection 73
The study was approved by the ethics committee of Jinhua municipal central hospital. Electronic 74 databases including Pubmed, Google scholar, Embase and Scopus were searched from inception 75 to April 2014. The core search terms consisted of cigarette smoking and ALI/ARDS. Detailed 76 searching strategy and results performed in Pubmed were shown in appendix file. The searching 77 strategy was adapted to other databases and results were not shown here.
79
Studies were included if they investigated the association of cigarette smoking and ALI/ARDS. 80
Both cohort and case--control studies were included irrespective of they were retrospective or 81 prospective in design. Methodology used to investigate the association between smoking and 82 ALI/ARDS included multivariable analysis and matching technique. Exclusion criteria were 1) 83 non--human experimental studies; 2) studies investigate the prognostic value of cigarette 84 smoking in ARDS patients (patients were already confirmed to have ARDS at enrollment); and 3) 85 studies used duplicated cohort with other studies. 86 publication, study population and settings, study design (prospective vs retrospective), sample 89 size, incidence of ALI/ARDS, definitions of cigarette smoking, the number of covariates used for 90 risk adjustment, and outcome of interest (ARDS or ALI or both), odds ratio (OR) or risk ratio (RR) 91 of smoking for ALI/ARDS development. For studies reported OR or RR for more than one 92 multivariable models, we extracted the one adjusted by the largest number of covariates. 93 94 95
Quality assessment with Newcastle--Ottawa scale 96
Non--randomized studies were assessment for their methodological quality by using 97
Newcastle--Ottawa scale.
[14] The scale comprised three major parts: selection, comparability and 98 outcome. Selection was assessed from four aspects including representativeness of exposed 99 cohort, selection of non--exposed cohort, ascertainment of exposure and demonstration that 100 outcome of interest was not present at start of study. One star can be assigned to each item if 101 the condition was satisfied. Comparability was assessed on the basis of the design or analysis. A 102 maximum of 2 stars can be allotted in this category. Outcome comprised three components: 103 assessment of outcome, was follow--up long enough for outcomes to occur and adequacy of 104 follow up cohort. One star can be assigned to each item if the condition is considered to be 105 adequate. 106 107
Statistical analysis 108 109
Due to expected heterogeneity in study population, we used random effects model for analysis. 110
The parameter τ 2 (tau--squared) is the between study variance and can be estimated by using 111
DerSimonian and Laird method: 112
where k is the number of included studies, and 115
Then, the total variance was composed of the between--study variance and within study variance, 116 and the mean OR was estimated by using inverse--variance method.
[15] Heterogeneity was 117 quantified as the proportion of between--study variance in the total variance, and can be written 118 as 119
Values on the order of 25%, 50% and 75% can be considered as low, moderate and high 120 heterogeneity. 121 122 transformed RR to OR by the equation: 124
Where RR is relative risk, OR id odds ratio and P0 indicates absolute risk in the non--smoker group, 125
given as a fraction (e.g. fill in 10% risk as 0.1).
[16] When P0<0.1, we approximate OR with RR: 126
OR ≈ RR. 127
Publication bias was assessed by using Egger's test. Standard normal deviate (SND), defined as 128 the odds ratio divided by its standard error, was regressed against the precision of OR. Precision 129 of OR was defined as the inverse of the standard error. 130
Where a is the intercept and b is the slope indicating the size and direction of the effect. 131
Intercept a provides a measure of asymmetry: the larger its deviation from zero the more 132 pronounced the asymmetry. Characteristics of included studies are shown in table 1. Six studies(10,12,18,20,25) involved 147 patients underwent major surgery; three studies(11,13,26) were population based studies; and 148 others involved patients with other risks of ALI/ARDS such as septic shock(19), influenza A 149 infection(22--24), trauma(23,27), transfusion(30). Five studies were prospective in design and 11 150 were retrospective. The sample sizes varied substantially across studies ranging from 16 to 151 121012. Population--based studies had much larger sample size than others and the incidence of 152 ALI/ARDS was expectedly much lower. In general population, the incidence of ARDS was 153 0.046%, [11] whereas the incidence of ARDS can be as high as 40% in patients with septic 154 shock [19] The quality of component studies was assessed by using the Newcastle--Ottawa scale (figure 2). cohorts were not adequate in 8 studies (47.1%, no star), one star was assigned in 3 studies 166 (17.6%), and two stars were assigned for 6 studies (35.3%). Outcome of interest was not present 167 in all cohorts. Representativeness of the exposed and control cohort was not adequate in 5 168 studies (29.4%). 169 170 171
Five studies did not report effect size (OR or RR) of cigarette smoking for ALI/ARDS development. 172
Two studies[10 18] stated cigarette smoking is an independent risk factor for ARDS, but the 173 effect size was not reported. One study [19] employed smoking as a covariate to adjust for other 174 variable of interest. One study [20] reported that all patients in the cohort had history of smoking. 175
The last study[24] did not linked smoking with respiratory failure quantitatively. Four studies 176 demonstrated cigarette smoking as a risk factor for the development of ALI/ARDS,[11 12 22 27] 177
whereas the remaining studies did not show any increased risk of ALI/ARDS in patients with 178 history of smoking (figure 3). Although there was no statistical heterogeneity (I--squared=0%), we 179 still combined the result with random--effects model because of the heterogeneous study 180 populations. The combined results showed that cigarette smoking was not a risk factor for the 181 development of ALI/ARDS (OR: 1.00, 95% CI: 0.99--1.01). In subgroup analysis, the same result 182 was obtained in general population (OR: 2.03, 95% CI: 0.06--4.01), patients with major surgery or 183 trauma (OR: 1.20, 95% CI: 0.48--1.93) and patients with other risks of ALI/ARDS (OR: 1.00, 95% CI: 184 0.99--1.01). Publication bias was present with Egger's test ( figure 4) . The result showed that small 185 studies reported larger OR (smoking as a risk factor for ALI/ARDS) were more likely to be 186 published (95% confidence interval did not include the reference line). 187 188
Discussion 189
The study demonstrates that cigarette smoking is not significantly associated with ALI/ARDS. 190
However, only one study [11] investigated the association of cigarette smoking and ARDS in 191 general population and found that smoking was associated with significantly increased risk of 192 ARDS (OR: 4.59, 95% CI: 2.13--9.88). The other population--based study[26] used recurrent ALI as 193 the outcome of interest and showed no significant association between smoking and recurrent 194 ALI. Because the event rate in population--based study was very low, the positive finding can 195 happen by chance and require further confirmation. In the author's view, placing ALI/ARDS in 196 general population is of limited interest to clinicians because of extremely low incidence in 197 general healthy population. In contrast, investigating ALI/ARDS in high risk patients is more 198 relevant, that is, we are more interested in patients who are at risk of ALI/ARDS and for whom 199 particular interventions can be initiated to prevent or postpone its occurrence. 200 201
Our study refutes previous findings that cigarette smoking can be an underlying cause of 202 ALI/ARDS. In experimental studies, active smoking is associated with morphological alterations in 203 lung epithelium and endothelium similar to that seen in ARDS.[31--33] Furthermore, studies 204 involving human subjects have shown that smokers (as compared with non--smokers) have 205 greater pulmonary epithelial permeability which is considered to be a hallmark of ARDS. Active 206 smoking also reduces the expression of ion channels that are responsible for resolving pulmonary edema.[34--36] However, these experimental studies were conducted in strictly 208 controlled experimental conditions that may not be replicable in real world setting. There are 209 numerous confounding factors in the real world that may act to mask the biological effect of 210 cigarette smoking. Alternatively, the effect of cigarette smoking may be too small as compared 211 to other precipitating factors to be detected in studies with limited sample size. 212 213
However, the study failed to show significant association of cigarette smoking and ALI/ARDS in 214 varieties of conditions such as major surgery, severe trauma, transfusion, septic shock and 215 influenza A infection. The incidence of ALI/ARDS in these conditions was much higher than that 216 in general population. The difference between general population and these medical conditions 217 lies in the fact that patients are more critically ill and requires ICU admission. Such severe 218 conditions may obliterate the impact of cigarette smoking because this impact is so small that it 219 is negligible as compared with other precipitating factors. A small effect size is subject to false 220 negative findings if statistical power is compromised by limited sample size. As a matter of fact, 221 the sample sizes in studies involving critically ill patients were relatively small, which may partly 222 explain the negative findings in these sub--populations. Furthermore, the publication bias was 223 identified by using Egger's test, that is, studies with negative findings in terms of the association 224 of cigarette smoking and ALI/ARDS were less likely to report the effect size (OR or RR). For 225 instance, the study by Moss M and coworkers used cigarette smoking as a covariate to adjust for 226 other variables of interest but finally did not reported the coefficient for cigarette smoking.
[19] 227
The publication bias further support our finding that cigarette smoking is less likely to increase 228 the risk of ALI/ARDS in critically ill patients. Small study effect is a phenomenon in 229 meta--epidemiological field that meta--analyses including small study are more likely to report 230 larger effect size.
[37] Such effect may also take place in the current meta--analysis in which 231 component studies involving critically ill patients were generally small. However, due to the 232 neutral finding in the study, the small study effect acts as a confirmation on the neutral effect of 233 cigarette smoking. 234 235
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